Tempus AI shares jump amid Medicare revenue optimism
Tempus AI stock rose 15% on Thursday and has advanced 36% over five sessions, after investor focus on expected Medicare reimbursement revenue for two cancer screenings.
Tempus AI shares advanced this week after investors got clearer on how much revenue the company could generate through Medicare reimbursements for two of its cancer screenings. The stock gained 15% Thursday and has risen 36% over the last five sessions. Shares moved toward their hi…